- $43.10m
- $95.50m
- $1.16bn
- 20
- 56
- 42
- 34
Annual balance sheet for Neuehealth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Net Total Receivables | — | — | — | 99.2 | 116 |
| Prepaid Expenses | |||||
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 17.3 | 39.2 | 83.7 | 42.6 | 14.5 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Insurance Receivables | |||||
| Other Long Term Assets | |||||
| Total Other Assets | |||||
| Total Assets | 820 | 1,811 | 3,598 | 4,665 | 1,225 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Policy Liabilities | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 212 | 633 | 2,453 | 3,945 | 1,569 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 609 | 1,177 | 1,145 | 720 | -344 |
| Total Liabilities & Shareholders' Equity | 820 | 1,811 | 3,598 | 4,665 | 1,225 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |